
Nature Immunology, Published online: 02 January 2026; doi:10.1038/s41590-025-02367-5
New data show that DNGR-1 enables type 1 conventional dendritic cells to sculpt cancer immunoediting through selective cross-presentation of F-actin-tethered neoantigens, enriching tumors for immune-evasive variants.
Read more about this post…
Credits: Source
Disclaimer




Serving